Literature DB >> 15905311

Clinical vitamin B6 analysis: an interlaboratory comparison of pyridoxal 5'-phosphate measurements in serum.

Michael E Rybak1, Ram B Jain, Christine M Pfeiffer.   

Abstract

BACKGROUND: Recent investigations into the role vitamin B(6) plays in reducing risk of stroke and cardiovascular disease have heightened interest in vitamin B(6) intake and its relationship to clinical status indicators. Because a true reference method and certified reference materials are lacking, little is known about the relative analytical performance of clinical vitamin B(6) assays.
METHODS: Ten laboratories experienced in clinical vitamin B(6) analysis participated in a 3-day analysis of 69 serum and 3 aqueous specimens for pyridoxal 5'-phosphate (PLP). Laboratories used either HPLC-based or enzymatic assays. Results were analyzed for imprecision, recovery, and bias relative to consensus means.
RESULTS: Among laboratories, mean within-day CVs (3 specimens x 3 measurements/day) were 0.6%-37% and between-day CVs (20 specimens x 1 measurement/day x 3 days) were 1.4%-26%. Mean recoveries of added PLP were 53%-144%, and mean sample pool mixing recoveries were 75%-119%. Consensus means calculated for 20 serum specimens gave mean relative biases between measurement of -10.0% to 24.3% among participating laboratories over a range of 15.8-319 nmol/L PLP. Measurement imprecision and biases were evaluated against empirically derived performance criteria based on biological variation. Three of 10 laboratories met optimum imprecision requirements and had 90% or more of measurements satisfy optimum criteria for biases among methods. All 10 laboratories met minimum imprecision requirements, but 25%-53% of the results reported by 4 of the 7 suboptimal laboratories failed to satisfy the minimum criteria for bias.
CONCLUSION: Agreement among vitamin B(6) methods is good, but large differences in laboratory proficiency exist, pointing to the need for vitamin B(6) reference materials and external quality assurance programs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905311     DOI: 10.1373/clinchem.2005.050278

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Presence of circulating folic acid in plasma and its relation with dietary intake, vitamin B complex concentrations and genetic variants.

Authors:  Josiane Steluti; Christina Reginaldo; Jacob Selhub; Ligi Paul; Regina Mara Fisberg; Dirce Maria Marchioni
Journal:  Eur J Nutr       Date:  2018-11-02       Impact factor: 5.614

2.  Suboptimal maternal and cord plasma pyridoxal 5' phosphate concentrations are uncommon in a cohort of Canadian pregnant women and newborn infants.

Authors:  Lesley Plumptre; Shannon P Masih; Kyoung-Jin Sohn; Denise Kim; Carly E Visentin; Anna Ly; Howard Berger; Ruth Croxford; Deborah L O'Connor; Young-In Kim
Journal:  Matern Child Nutr       Date:  2017-05-24       Impact factor: 3.092

3.  Simultaneous Determination of Underivatized Vitamin B1 and B6 in Whole Blood by Reversed Phase Ultra High Performance Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Johan Puts; Monique de Groot; Martin Haex; Bernadette Jakobs
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

4.  A quantile regression approach can reveal the effect of fruit and vegetable consumption on plasma homocysteine levels.

Authors:  Eliseu Verly; Josiane Steluti; Regina Mara Fisberg; Dirce Maria Lobo Marchioni
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

5.  Genetic Variants Involved in One-Carbon Metabolism: Polymorphism Frequencies and Differences in Homocysteine Concentrations in the Folic Acid Fortification Era.

Authors:  Josiane Steluti; Aline M Carvalho; Antonio A F Carioca; Andreia Miranda; Gilka J F Gattás; Regina M Fisberg; Dirce M Marchioni
Journal:  Nutrients       Date:  2017-05-25       Impact factor: 5.717

6.  Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations.

Authors:  Øivind Midttun; Despoina Theofylaktopoulou; Adrian McCann; Anouar Fanidi; David C Muller; Klaus Meyer; Arve Ulvik; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang; Ross Prentice; Cynthia A Thomson; Mary Pettinger; Graham G Giles; Allison Hodge; Qiuyin Cai; William J Blot; Jie Wu; Mikael Johansson; Johan Hultdin; Kjell Grankvist; Victoria L Stevens; Marjorie L McCullough; Stephanie J Weinstein; Demetrius Albanes; Arnulf Langhammer; Kristian Hveem; Marit Næss; Howard D Sesso; J Michael Gaziano; Julie E Buring; I-Min Lee; Gianluca Severi; Xuehong Zhang; Jiali Han; Meir J Stampfer; Stephanie A Smith-Warner; Anne Zeleniuch-Jacquotte; Loic le Marchand; Jian-Min Yuan; Lesley M Butler; Woon-Puay Koh; Renwei Wang; Yu-Tang Gao; Ulrika Ericson; Emily Sonestedt; Regina G Ziegler; Neal D Freedman; Kala Visvanathan; Miranda R Jones; Caroline Relton; Paul Brennan; Mattias Johansson; Per M Ueland
Journal:  Am J Clin Nutr       Date:  2017-04-19       Impact factor: 7.045

7.  A one-step NIST traceable HPLC method for quantitation of vitamin B6 and 4-pyridoxic acid in human plasma.

Authors:  Xiaochun Zhang; Xiaoying Tang; Thomas M Daly
Journal:  Pract Lab Med       Date:  2020-04-07

8.  Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions.

Authors:  Markus Schulze; Maria Hutterer; Anja Sabo; Sabine Hoja; Julia Lorenz; Tanja Rothhammer-Hampl; Christel Herold-Mende; Lucia Floßbach; Camelia Monoranu; Markus J Riemenschneider
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.